Merck accuses US of ‘extortion’ in lawsuit against drug price controls
Merck has sued the US over a law that hands the federal government the power to negotiate prices for some of the most expensive drugs, arguing that key parts of the legislation are unconstitutional and “tantamount to extortion”.
The US drugmaker said on Tuesday the reforms contained in the Inflation Reduction Act, a key part of President Joe Biden’s agenda to reduce the cost of prescription medicines, violated the first and fifth amendments to the US constitution.
This story originally appeared on: Financial Times - Author:Jamie Smyth
